Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -1.01 |
| peg ratio | 0.06 |
| price to book ratio | 0.85 |
| price to sales ratio | 1.27 |
| enterprise value multiple | -1.92 |
| price fair value | 0.85 |
profitability ratios | |
|---|---|
| gross profit margin | 50.27% |
| operating profit margin | -55.48% |
| pretax profit margin | -125.12% |
| net profit margin | -114.41% |
| return on assets | -45.92% |
| return on equity | -73.79% |
| return on capital employed | -28.08% |
liquidity ratio | |
|---|---|
| current ratio | 1.01 |
| quick ratio | 0.85 |
| cash ratio | 0.28 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 61.29 |
| operating cycle | 137.66 |
| days of payables outstanding | 164.14 |
| cash conversion cycle | -26.48 |
| receivables turnover | 4.78 |
| payables turnover | 2.22 |
| inventory turnover | 5.96 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.27 |
| debt equity ratio | 0.50 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.33 |
| interest coverage | -27.70 |
| cash flow to debt ratio | -0.44 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.30 |
| cash per share | 0.13 |
| operating cash flow per share | -0.25 |
| free cash flow operating cash flow ratio | 1.19 |
| cash flow coverage ratios | -0.44 |
| short term coverage ratios | -2.32 |
| capital expenditure coverage ratio | -5.16 |
Frequently Asked Questions
ImmunoPrecise Antibodies Ltd. (IPA) published its most recent earnings results on 10-12-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA)'s trailing twelve months ROE is -73.79%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ImmunoPrecise Antibodies Ltd. (IPA) currently has a ROA of -45.92%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
IPA reported a profit margin of -114.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.01 in the most recent quarter. The quick ratio stood at 0.85, with a Debt/Eq ratio of 0.50.